UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites

Cancer research (Chicago, Ill.), 1983-09, Vol.43 (9), p.4443-4447

1983

Volltextzugriff (PDF)

Appropriate frontal barrier tests for belted occupants

Accident analysis and prevention, 1995-12, Vol.27 (6), p.807-817

1995

Volltextzugriff (PDF)

Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture

Cancer research (Chicago, Ill.), 1982-03, Vol.42 (3), p.1116-1119

1982

Volltextzugriff (PDF)

Increased secretion of insulin-like growth factor-binding proteins and decreased secretion of insulin-like growth factor-II by muscle from growth-retarded neonatal rats

Journal of endocrinology, 1991-07, Vol.130 (1), p.33-42

1991

Volltextzugriff (PDF)

Receptors for 1,25(OH)2‐vitamin D3 enriched in cloned osteoblast‐like rat osteogenic sarcoma cells

FEBS letters, 1980-06, Vol.115 (1), p.139-142

1980

Volltextzugriff (PDF)

Effect on the fetus of infusing a commercial amino acid preparation into a pregnant sheep

Biology of the neonate, 1990, Vol.57 (3-4), p.231-237

1990

Volltextzugriff (PDF)

Regulation of the 1,25-dihydroxyvitamin D3 receptor by 1,25-dihydroxyvitamin D3 in intact human cancer cells

Endocrinology (Philadelphia), 1985-03, Vol.116 (3), p.971-977

1985

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells)

Biochemical and biophysical research communications, 1980-03, Vol.93 (1), p.9-15

1980

Volltextzugriff (PDF)

NORMAL AND MALIGNANT BREAST TISSUE IS A TARGET ORGAN FOR 1, 25-(OH)2 VITAMIN D3

Clinical endocrinology (Oxford), 1980-09, Vol.13 (3), p.267-272

1980

Volltextzugriff (PDF)

Changes in plasma amino acids in the developing chick

Biology of the neonate, 1986-01, Vol.50 (3), p.154-159

1986

Volltextzugriff (PDF)

Failure of IGF-1 to affect protein turnover in muscle from growth-retarded neonatal rats

Journal of developmental physiology, 1990-03, Vol.13 (3), p.125

1990

Volltextzugriff (PDF)

Biochemical significance of enhanced activity of fluorinated 1,25-dihydroxyvitamin D3 in human cultured cell lines

Cell biochemistry and function, 1986-04, Vol.4 (2), p.115-122

1986

Volltextzugriff (PDF)

1,25-DIHYDROXYVITAMIN D3 AND BREAST CANCER

Australian and New Zealand Journal of Surgery, 1984-02, Vol.54 (1), p.17-20

1984

Volltextzugriff (PDF)

1α,25-Dihydroxyvitamin D3 specifically induces its own metabolism in a human cancer cell line

Endocrinology (Philadelphia), 1984, Vol.114 (4), p.1225-1231

1984

Volltextzugriff (PDF)

Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines

Cancer research (Chicago, Ill.), 1980-12, Vol.40 (12), p.4764-4767

1980

Volltextzugriff (PDF)

1 alpha, 25-Dihydroxyvitamin D3 specifically induces its own metabolism in a human cancer cell line

Endocrinology (Philadelphia), 1984-04, Vol.114 (4), p.1225-1231

1984

Volltextzugriff (PDF)

The potential for further development of passive safety

Annals of advances in automotive medicine, 2009-10, Vol.53, p.51

2009

Volltextzugriff (PDF)

1 α ,25-Dihydroxyvitamin D 3 Specifically Induces Its Own Metabolism in a Human Cancer Cell Line

Endocrinology (Philadelphia), 1984-04, Vol.114 (4), p.1225-1231

1984

Volltextzugriff (PDF)

1 alpha ,25-Dihydroxyvitamin D sub(3) specifically induces its own metabolism in a human cancer cell line

Endocrinology (Philadelphia), 1984-01, Vol.114 (4), p.1225-1231

1984

Volltextzugriff (PDF)

Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D sub(3) metabolites

Cancer research (Chicago, Ill.), 1983-01, Vol.43 (9), p.4443-4447

1983

Volltextzugriff (PDF)

NORMAL AND MALIGNANT BREAST TISSUE IS A TARGET ORGAN FOR 1, 25‐(OH) 2 VITAMIN D 3

Clinical endocrinology (Oxford), 1980-09, Vol.13 (3), p.267-272

1980

Volltextzugriff (PDF)

ULTRAFINE PARTICLE CONCENTRATIONS IN A HOSPITAL

Inhalation toxicology, 2000, Vol.12 (S2), p.83-94

Riesenfeld, D. Chalupa, F. R. Gibb, G. Oberdo, R. Gelein, P. E. Morrow, M. J. Utell, M. W. Frampton, E.

2000

Volltextzugriff (PDF)

Calcitonin and 1,25-Dihydroxyvitamin D sub(3) Receptors in Human Breast Cancer Cell Lines

Cancer research (Chicago, Ill.), 1980-01, Vol.40 (12), p.4764-4767

1980

Volltextzugriff (PDF)

1,25‐DIHYDROXYVITAMIN D 3 AND BREAST CANCER

Australian and New Zealand journal of surgery, 1984-02, Vol.54 (1), p.17-20

1984

Volltextzugriff (PDF)

Juvenile wood specific gravity of loblolly pine tissue culture plantlets and seedlings

Canadian journal of forest research, 1989-10, Vol.19 (10), p.1347-1350

1989

Volltextzugriff (PDF)

1 – 25 von 727

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(652)
Mit Volltextzugriff
(618)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(476)
Life Sciences & Biomedicine
(400)
Humans
(313)
Female
(203)
Male
(182)
Biological And Medical Sciences
(149)
Adult
(133)
Middle Aged
(129)
Aged
(106)
Medical Sciences
(105)
Animals
(84)
Adolescent
(51)
Oncology
(51)
Physical Sciences
(51)
Aged, 80 And Over
(48)
Fundamental And Applied Biological Sciences. Psychology
(47)
Treatment Outcome
(39)
Risk Factors
(37)
Cardiovascular System & Cardiology
(33)
Chemistry
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites

Appropriate frontal barrier tests for belted occupants

Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture

Increased secretion of insulin-like growth factor-binding proteins and decreased secretion of insulin-like growth factor-II by muscle from growth-retarded neonatal rats

Receptors for 1,25(OH)2‐vitamin D3 enriched in cloned osteoblast‐like rat osteogenic sarcoma cells

Effect on the fetus of infusing a commercial amino acid preparation into a pregnant sheep

Regulation of the 1,25-dihydroxyvitamin D3 receptor by 1,25-dihydroxyvitamin D3 in intact human cancer cells

1,25-Dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells)

NORMAL AND MALIGNANT BREAST TISSUE IS A TARGET ORGAN FOR 1, 25-(OH)2 VITAMIN D3

Changes in plasma amino acids in the developing chick

Failure of IGF-1 to affect protein turnover in muscle from growth-retarded neonatal rats

Biochemical significance of enhanced activity of fluorinated 1,25-dihydroxyvitamin D3 in human cultured cell lines

1,25-DIHYDROXYVITAMIN D3 AND BREAST CANCER

1α,25-Dihydroxyvitamin D3 specifically induces its own metabolism in a human cancer cell line

Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines

1 alpha, 25-Dihydroxyvitamin D3 specifically induces its own metabolism in a human cancer cell line

The potential for further development of passive safety

1 α ,25-Dihydroxyvitamin D 3 Specifically Induces Its Own Metabolism in a Human Cancer Cell Line

1 alpha ,25-Dihydroxyvitamin D sub(3) specifically induces its own metabolism in a human cancer cell line

Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D sub(3) metabolites

NORMAL AND MALIGNANT BREAST TISSUE IS A TARGET ORGAN FOR 1, 25‐(OH) 2 VITAMIN D 3

ULTRAFINE PARTICLE CONCENTRATIONS IN A HOSPITAL

Calcitonin and 1,25-Dihydroxyvitamin D sub(3) Receptors in Human Breast Cancer Cell Lines

1,25‐DIHYDROXYVITAMIN D 3 AND BREAST CANCER

Juvenile wood specific gravity of loblolly pine tissue culture plantlets and seedlings

Suchergebnisse filtern